Expert: results of an exit JOINT-STOCK COMPANY "ROSNANO" from "Nanolek" - an example of system effectiveness of state support

Show original
The director of RNC Pharma Rasshchupkin Pawel considers that this transaction will have positive impact on investment climate to Russian Federation...

Full article is available at its source

Go to full article
Open the Connections Tree and see if Moscow and are connected in any way
Try it

Sign up for more features!

Get full access to news analytics for free and without ads.

in this article
Anatoly Chubais
Last position: Director general of JSC RUSNANO (JSC Rusnano)
Rasshchupkin Pawel
Konov Aleksey
Khristenko Vladimir
Nekrasov Mikhail
in this article
JSC Rusnano
Main activity:Finance
Novartis Int AG
Main activity:Health care and social services
LLC "Nanolek"